Literature DB >> 10340860

Hypoxia upregulates VEGF production in keloid fibroblasts.

D S Steinbrech1, B J Mehrara, D Chau, N M Rowe, G Chin, T Lee, P B Saadeh, G K Gittes, M T Longaker.   

Abstract

The etiology of keloid formation is diverse. They are characterized grossly as thick scar tissue that extends beyond the boundaries of the original wound. Histologically, keloids are composed of excessive collagen with an abnormally large number of partially or totally occluded microvessels. This occlusion of keloid microvessels has been hypothesized to contribute to a hypoxic microenvironment within these pathological scars. Vascular endothelial growth factor (VEGF), a potent endothelial cell mitogen, and proangiogenic cytokine have been implicated in normal and pathological wound healing. The purpose of this study was to evaluate the amount of VEGF protein production by fibroblast cell lines derived from keloids and normal human dermal skin in hypoxic compared with normoxic culture conditions. By enzyme-linked immunosorbent protein assay, VEGF was increased in both keloid and normal human dermal fibroblasts in hypoxia over normoxic controls. There was not, however, a significant difference between upregulation of VEGF protein when comparing the keloid and normal fibroblast groups. As the result of the data, alternative hypotheses for hypoxia-induced keloid formation were explored: (1) downstream modulation or signal transduction of VEGF, (2) VEGF production from cells other than fibroblasts, (3) the importance of matrix accumulation stimulated by hypoxia, or (4) increased migration of cells (other than fibroblasts) specific to keloid biology. These hypotheses may help explain the possible role of hypoxia in the pathogenesis of keloid formation. Future studies involving in situ hybridization or immunohistochemical analysis may offer greater insight into the mechanisms underlying keloid formation. Ultimately, our therapeutic goal is the utilization of biomolecular approaches for the suppression of keloid formation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340860     DOI: 10.1097/00000637-199905000-00009

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  13 in total

1.  Innovative therapies in the treatment of keloids and hypertrophic scars.

Authors:  Martha H Viera; Sadegh Amini; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-05

2.  Recombinant human endostatin reduces hypertrophic scar formation in rabbit ear model through down-regulation of VEGF and TIMP-1.

Authors:  Peng Wang; Li-Zhu Jiang; Bin Xue
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

3.  Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth.

Authors:  S R Boyd; D S W Tan; L de Souza; M H Neale; N E Myatt; R A Alexander; M Robb; J L Hungerford; I A Cree
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

4.  Erythropoietin ameliorates the reduced migration of human fibroblasts during in vitro hypoxia.

Authors:  Stephanie Breit; Monika Bubel; Tim Pohlemann; Martin Oberringer
Journal:  J Physiol Biochem       Date:  2010-09-04       Impact factor: 4.158

5.  Effect of human Wharton's jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts.

Authors:  Anna I Arno; Saeid Amini-Nik; Patrick H Blit; Mohammed Al-Shehab; Cassandra Belo; Elaine Herer; Marc G Jeschke
Journal:  Stem Cells Transl Med       Date:  2014-01-16       Impact factor: 6.940

Review 6.  Pericytes: multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle.

Authors:  Alexander Birbrair; Tan Zhang; Zhong-Min Wang; Maria L Messi; Akiva Mintz; Osvaldo Delbono
Journal:  Front Aging Neurosci       Date:  2014-09-18       Impact factor: 5.750

7.  Keloid-derived keratinocytes acquire a fibroblast-like appearance and an enhanced invasive capacity in a hypoxic microenvironment in vitro.

Authors:  Xiaoyang Ma; Jia Chen; Bei Xu; Xiao Long; Han Qin; Robert Chunhua Zhao; Xiaojun Wang
Journal:  Int J Mol Med       Date:  2015-03-13       Impact factor: 4.101

8.  Significant improvement of direct reprogramming efficacy of fibroblasts into progenitor endothelial cells by ETV2 and hypoxia.

Authors:  Phuc Van Pham; Ngoc Bich Vu; Hoa Trong Nguyen; Oanh Thuy Huynh; Mai Thi-Hoang Truong
Journal:  Stem Cell Res Ther       Date:  2016-08-04       Impact factor: 6.832

9.  Hypoxia drives the transition of human dermal fibroblasts to a myofibroblast-like phenotype via the TGF-β1/Smad3 pathway.

Authors:  Bin Zhao; Hao Guan; Jia-Qi Liu; Zhao Zheng; Qin Zhou; Jian Zhang; Lin-Lin Su; Da-Hai Hu
Journal:  Int J Mol Med       Date:  2016-12-01       Impact factor: 4.101

Review 10.  Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.

Authors:  Ho Jun Lee; Yong Ju Jang
Journal:  Int J Mol Sci       Date:  2018-03-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.